Dr Mark Kris discusses the increasing precision of lung cancer therapies and the need for additional testing to find ...
Tempus AI, Inc. , a technology company leading the adoption of AI to advance precision medicine, today announced the launch ...
Opportunities in the Global Refractory Follicular Lymphoma Diagnostics Market include the growing need for MRD monitoring and ...
Daiichi Sankyo & AstraZeneca’s Enhertu approved in China as first and only HER2 directed ADC for second-line treatment of patients with HER2 positive metastatic gastric cancer ...
Resource drilling at PTR Minerals’ Rosewood Titanium project in South Australia’s Gawler Craton has returned some of the ...
EMA validates Enhertu plus pertuzumab type II variation application in EU as first-line treatment of patients with HER2 positive metastatic breast cancer: Tokyo Tuesday, January 2 ...
Daiichi Sankyo and AstraZeneca's Enhertu has been cleared for previously-untreated HER2-positive breast cancer in the US, becoming the first new first-line option in more than a decade. The FDA ...
Cancer patients paid the same premium, but phone calls allegedly unlocked extra approvals for some, forcing others into ...
The Express Tribune on MSN
Court cancels bail of Imaan Mazari, husband in social media posts case
A district court in Islamabad on Thursday cancelled the bail of lawyer and activist Imaan Mazar and her husband, Hadi Ali Chattha, in a case related to controversial social media posts, citing ...
Researchers explored why only 40 percent of patients responded to Amgen's Imdelltra using TellBio's liquid biopsy test and ...
Patients and medical professionals say the guidelines listed in the Gazette are being varied depending on who you know at SHA ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback